Wenlei Zhuo Selected Research

Wenlei Zhuo Research Topics

Disease

19	Neoplasms (Cancer) 09/2023 - 06/2006
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 03/2012
7	Lung Neoplasms (Lung Cancer) 07/2021 - 10/2008
5	Carcinoma (Carcinomatosis) 01/2023 - 01/2009
4	Adenocarcinoma of Lung 01/2016 - 06/2006
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2023 - 01/2013
2	Breast Neoplasms (Breast Cancer) 05/2017 - 08/2009
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2012 - 01/2012
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2012 - 01/2012
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Sigmoid Neoplasms 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Radiation Pneumonitis 03/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2022
1	Ovarian Teratoma 07/2021
1	Melanoma (Melanoma, Malignant) 07/2021
1	Teratoma (Teratoid Tumor) 07/2021
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Lung Diseases (Lung Disease) 12/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2015
1	Sepsis (Septicemia) 01/2013
1	Toxemia 01/2013
1	Meningitis 01/2013
1	Esophageal Neoplasms (Esophageal Cancer) 11/2012
1	Exanthema (Rash) 03/2012
1	Nausea 03/2012
1	Dyspnea (Shortness of Breath) 03/2012
1	Diarrhea 03/2012
1	Vomiting 03/2012
1	Cough 03/2012
1	Constipation 03/2012
1	Anorexia 03/2012
1	Fatigue 03/2012
1	Stomach Neoplasms (Stomach Cancer) 01/2012
1	Leukemia 01/2012
1	Mouth Neoplasms (Oral Cancer) 01/2009
1	Lymphatic Metastasis 06/2008

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 12/2022 - 05/2017
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2015
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2015
4	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 11/2012 - 01/2009
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2022 - 01/2015
3	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 10/2008
2	CadmiumIBA 09/2023 - 01/2023
2	Cytokine Receptors (Cytokine Receptor)IBA 09/2023 - 05/2017
2	CytokinesIBA 09/2023 - 05/2017
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
2	Histone Deacetylases (Histone Deacetylase)IBA 12/2022 - 01/2015
2	FlavonoidsIBA 01/2016 - 01/2015
2	fisetinIBA 01/2016 - 01/2015
2	arginylarginine (Arg-Arg)IBA 01/2013 - 08/2009
1	Fibronectins (Fibronectin)IBA 09/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2023
1	Heavy MetalsIBA 09/2023
1	Cetuximab (Erbitux)FDA Link 01/2023
1	Bevacizumab (Avastin)FDA Link 01/2023
1	EndostatinsIBA 03/2022
1	endostar proteinIBA 03/2022
1	camrelizumabIBA 07/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	ThymosinIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	IntegrinsIBA 10/2019
1	ArsenicIBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 04/2018
1	AntiportersIBA 04/2018
1	Cystine (L-Cystine)IBA 04/2018
1	Indicators and Reagents (Reagents)IBA 04/2018
1	Aurora Kinase AIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 12/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2017
1	Lapatinib (GW572016)FDA Link 05/2017
1	PhytochemicalsIBA 01/2016
1	CaspasesIBA 01/2015
1	3-hydroxyflavoneIBA 01/2015
1	SurvivinIBA 01/2015
1	Sorafenib (BAY 43-9006)FDA Link 01/2015
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2015
1	AntigensIBA 01/2013
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2013
1	ElementsIBA 01/2013
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2012
1	Cyclin D1IBA 11/2012
1	vandetanib (ZD6474)IBA 03/2012
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2012
1	valylvaline (Val-Val)IBA 01/2012
1	prolyl-proline (Pro-Pro)IBA 08/2009
1	Codon (Codons)IBA 08/2009
1	Hyaluronan ReceptorsIBA 06/2008
1	Hyaluronic Acid (Hyaluronan)IBA 06/2006
1	Small Interfering RNA (siRNA)IBA 06/2006

Therapy/Procedure

7	Therapeutics 01/2023 - 10/2008
4	Drug Therapy (Chemotherapy) 01/2023 - 03/2012
3	Radiotherapy 01/2023 - 07/2021
2	Immunotherapy 01/2023 - 07/2021
1	Adjuvant Chemotherapy 01/2023